Free Trial
NASDAQ:ICAD

icad Q2 2025 Earnings Report

icad logo
$3.87 0.00 (0.00%)
As of 07/17/2025

icad EPS Results

Actual EPS
N/A
Consensus EPS
-$0.06
Beat/Miss
N/A
One Year Ago EPS
N/A

icad Revenue Results

Actual Revenue
N/A
Expected Revenue
$4.81 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

icad Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

icad Earnings Headlines

icad (ICAD) Expected to Announce Quarterly Earnings on Tuesday
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.
iCAD Stockholders Approve Merger with RadNet
See More icad Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like icad? Sign up for Earnings360's daily newsletter to receive timely earnings updates on icad and other key companies, straight to your email.

About icad

icad (NASDAQ:ICAD), Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

View icad Profile

More Earnings Resources from MarketBeat